Metabolic Dysfunction–Associated Steatotic Liver Disease—The New Epidemic of Chronic Liver Disease
JAMA Network Open · 17.06.2025 · 8 (6) · e2516381
DOI: 10.1001/jamanetworkopen.2025.16381 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 17.06.2025. Verfasst von Pere Ginès und 2 weiteren Autor:innen. Beteiligte Einrichtung: Liver Unit, Hospital Clínic of Barcelona, Barcelona, Catalunya, Spain. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Liver Unit, Hospital Clínic of Barcelona, Barcelona, Catalunya, Spain.
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain.
- Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
- Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
- Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
- Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Zitieren
APA
Ginès, P., Serra-Burriel, M., & Kamath, P. S. (2025). Metabolic Dysfunction–Associated Steatotic Liver Disease—The New Epidemic of Chronic Liver Disease. JAMA Network Open, 8(6), e2516381. https://doi.org/10.1001/jamanetworkopen.2025.16381
Vancouver
Ginès P, Serra-Burriel M, Kamath PS. Metabolic Dysfunction–Associated Steatotic Liver Disease—The New Epidemic of Chronic Liver Disease. JAMA Network Open. 2025;8(6):e2516381. doi:10.1001/jamanetworkopen.2025.16381
BibTeX
@article{Gins2025,
author = {Ginès, Pere and Serra-Burriel, Miquel and Kamath, Patrick S},
title = {Metabolic Dysfunction–Associated Steatotic Liver Disease—The New Epidemic of Chronic Liver Disease},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {6},
pages = {e2516381},
doi = {10.1001/jamanetworkopen.2025.16381}
}
EUVIMED